Cardinal Health, Inc.

New York Stock Exchange
Back to all articles
Somewhat Bullish +45

IFM Investors Pty Ltd Has $9.08 Million Stake in Cardinal Health, Inc ...

AI-generated analysis

📈 IFM Investors Pty Ltd increased its Cardinal Health stake by 14.6% in Q1, adding 5,489 shares for a total holding of 42,962 shares valued at $9.08 million.

📉 Jones Financial Companies Lllp surged its position by 198.3%, acquiring an additional 14,034 shares to own 21,112 shares worth $27,000.

💰 Cardinal Health reported Q1 EPS of $3.17, surpassing analyst consensus estimates of $2.79 by $0.38.

📉 Revenue for the quarter reached $60.94 billion, falling short of the $62.10 billion expected by analysts.

🚀 The company raised its FY 2026 EPS guidance to a range of $10.70-$10.80, exceeding the average analyst expectation of $10.76.

💵 Cardinal Health increased its quarterly dividend to $0.5158, representing a yield of 0.9% and an annualized payout of $2.06.

📊 TD Cowen raised its price target to $255 with a 'buy' rating, while JPMorgan Chase lowered its target to $215 with a 'neutral' rating.

🏢 Institutional ownership stands at 87.17%, indicating strong interest from hedge funds and asset managers.

📈 The stock trades at a P/E ratio of 36.51 with a market capitalization of $55.93 billion.

📉 Revenue growth slowed to 11.0% year-over-year, though this remains robust compared to the prior year's performance.

Bullish Signals
  • Cardinal Health beat quarterly earnings expectations with EPS of $3.17 versus a consensus of $2.79.
  • The company raised its full-year 2026 guidance to an EPS range of $10.70-$10.80, above analyst forecasts.
  • IFM Investors and Jones Financial Companies Lllp significantly increased their stakes, signaling institutional confidence.
  • Cardinal Health increased its quarterly dividend to $0.5158 from the previous $0.51.
  • TD Cowen upgraded the price target to $255 and maintained a 'buy' rating on the stock.
  • Leerink Partners reiterated an 'outperform' rating with a high price target of $275.
Risk Factors
  • Cardinal Health missed quarterly revenue expectations, reporting $60.94 billion against a consensus of $62.10 billion.
  • JPMorgan Chase lowered its price target to $215 and assigned a 'neutral' rating to the stock.
  • Zacks Research downgraded the stock from a 'strong-buy' to a 'hold' rating in late June.
  • The company reported a negative return on equity of 92.61% for the quarter.
Full Analysis
IFM Investors Pty Ltd increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 14.6% during the first quarter, purchasing an additional 5,489 shares to hold a total of 42,962 shares valued at approximately $9.08 million. Several other institutional investors also adjusted their positions, with Jones Financial Companies Lllp significantly increasing its holding by 198.3% and multiple firms establishing new stakes in the fourth quarter. Analyst sentiment regarding Cardinal Health remains mixed but generally positive, with TD Cowen raising its price target to $255 and reaffirming a 'buy' rating, while JPMorgan Chase lowered its target to $215 with a 'neutral' rating. The consensus among 18 analysts is a 'Moderate Buy' with an average price target of $247.80, reflecting ongoing debate over the company's valuation and growth prospects. Financially, Cardinal Health reported strong quarterly earnings of $3.17 per share, beating analyst estimates by $0.38, though revenue of $60.94 billion missed expectations of $62.10 billion. The company raised its full-year 2026 guidance to an EPS range of $10.70-$10.80 and increased its quarterly dividend to $0.5158, signaling confidence in future cash flow generation despite the recent revenue miss. The healthcare distributor operates with a market capitalization of $55.93 billion and maintains a P/E ratio of 36.51. With institutional ownership at 87.17%, the stock is heavily held by professional investors who are closely monitoring its ability to sustain growth in supply chain services amidst competitive pressures and margin constraints.